Determinants of alpha-synuclein pathogenesis in Parkinson’s disease

Determinants of alpha-synuclein pathogenesis in Parkinson’s disease

Saved in:

Bibliographic Details
Main Authors:	Oriol Bárcenas, Marc Estivill-Alonso, Salvador Ventura
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-04-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-01357
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Imaging alpha-synuclein pathology in Parkinson’s disease
by: Ruiqing Ni
Published: (2026-04-01)

Bibliometric Analysis of Alpha-Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson’s Disease
by: Aigerim B. Utegenova, et al.
Published: (2025-01-01)

Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
by: María E. Jimenez-Capdeville, et al.
Published: (2025-01-01)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson’s Disease
by: Maria Graciela Cersosimo
Published: (2015-01-01)

Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease
by: Lydia Shen, et al.
Published: (2024-12-01)

Elevated plasma levels of alpha-synuclein are dispensable for Parkinson’s disease pathology
by: Jin-Young Jeong, et al.
Published: (2025-08-01)

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson’s Disease
by: Juan Antonio Castillo-Gonzalez, et al.
Published: (2017-01-01)

Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
by: Lingjia Xu, et al.
Published: (2016-01-01)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson’s disease
by: Maria Otero-Jimenez, et al.
Published: (2025-02-01)

Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform
by: Martin Schuler, et al.
Published: (2025-04-01)

Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson’s disease
by: Alysia Ross, et al.
Published: (2025-07-01)

c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation
by: Jyutia Nargish, et al.
Published: (2025-04-01)

Decoding crosstalk between neurotransmitters and α-synuclein in Parkinson’s disease: pathogenesis and therapeutic implications
by: Lihua Guan, et al.
Published: (2025-06-01)

Alpha‐synuclein RT‐QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients
by: Aron Emmi, et al.
Published: (2025-03-01)

Accumulation of alpha-synuclein pathology in the liver exhibits post-translational modifications associated with Parkinson’s disease
by: Martin Hallbeck, et al.
Published: (2024-12-01)

Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson’s disease patients
by: Gabriela S. Longo, et al.
Published: (2015-06-01)

Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.
by: Nicole K Polinski, et al.
Published: (2025-01-01)

Intermittent fasting reduces alpha-synuclein pathology and functional decline in a mouse model of Parkinson’s disease
by: Éva M. Szegő, et al.
Published: (2025-05-01)

Alpha-Synuclein Seed Amplification Assays in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis
by: Jamir Pitton Rissardo, et al.
Published: (2025-06-01)

Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein
by: Mariangela Massaro Cenere, et al.
Published: (2024-11-01)

Parkinson’s paradox: alpha-synuclein’s selective strike on SNc dopamine neurons over VTA
by: L. Phan, et al.
Published: (2025-07-01)

Longitudinal multi-omics in alpha-synuclein Drosophila model discriminates disease- from age-associated pathologies in Parkinson’s disease
by: Justin Moore, et al.
Published: (2025-03-01)

Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease
by: Irene Frigerio, et al.
Published: (2025-07-01)

BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson’s disease
by: Aya Jishi, et al.
Published: (2024-12-01)

Exploring the Potential of Biomimetic Peptides in Targeting Fibrillar and Filamentous Alpha-Synuclein—An In Silico and Experimental Approach to Parkinson’s Disease
by: Sophia A. Frantzeskos, et al.
Published: (2024-11-01)

Alpha-synuclein-induced upregulation of SKI family transcriptional corepressor 1: A new player in aging and Parkinson’s disease?
by: Lauren Barrett, et al.
Published: (2026-01-01)

Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)

Alpha-synuclein in cutaneous small nerve fibers
by: Siepmann T, et al.
Published: (2016-10-01)

Differential expression of alpha-synuclein in hippocampal neurons.
by: Katsutoshi Taguchi, et al.
Published: (2014-01-01)

The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons
by: Jace Jones-Tabah, et al.
Published: (2024-11-01)

A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
by: Dag Sehlin, et al.
Published: (2025-03-01)

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation
by: Chunyan Mu, et al.
Published: (2025-03-01)

Alpha-synuclein interacts with regulators of ATP homeostasis in mitochondria
by: Tetiana Serdiuk, et al.
Published: (2025-08-01)

Glutamatergic synaptic resilience to overexpressed human alpha-synuclein
by: Patrícia I. Santos, et al.
Published: (2025-08-01)

Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
by: A. R. Esteves, et al.
Published: (2011-01-01)

Alpha-synuclein aggregates trigger cardiolipin externalization and mitophagy
by: Rebeca Martín-Jiménez, et al.
Published: (2024-12-01)

The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression
by: Sohan Mikkilineni, et al.
Published: (2012-01-01)

Correction: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons
by: Jace Jones-Tabah, et al.
Published: (2024-12-01)